ASCEND
BY NTHRYS

NTHRYS › PhD Assistance › Pharmacogenetics

Pharmacogenetics

Field
▾
Category
▾

Pharmacogenetics

Select a category to explore research frontiers

Loading categories...

Research Frontiers in Acetylator Phenotype and Isoniazid Hepatotoxicity

Study of NAT2 gene polymorphisms determining acetylation capacity and predicting tuberculosis drug-induced liver injury susceptibility.

NAT2 Acetylator Polymorphisms in Drug-Induced Liver Injury
Slow Acetylator Phenotype and Isoniazid Metabolite Accumulation
Genetic Variation in N-Acetyltransferase Expression Heterogeneity
Hepatic Metabolic Bottlenecks in Tuberculosis Treatment Toxicity
Population Stratification and Acetylator Status in TB Therapeutics
Acetyl-CoA Depletion Mechanisms in Isoniazid Hepatotoxicity
Epigenetic Regulation of NAT2 and Drug Tolerance Phenotypes
Mitochondrial Dysfunction Downstream of Toxic Metabolite Accumulation
Acetylator Phenotype as Biomarker for Personalized Isoniazid Dosing
Environmental Modifiers of NAT2-Driven Drug Response Variability

All Pharmacogenetics PhD categories